Joseph Vassalotti, MD (@joe_vassalotti) 's Twitter Profile
Joseph Vassalotti, MD

@joe_vassalotti

Nephrologist @NKF Chief Medical Officer @ISMMSKidney Clinical Professor - kidney and cardiovascular health guided by albuminuria and eGFR.

ID: 959091460799950848

linkhttps://link.springer.com/book/10.1007/978-3-030-30892-6 calendar_today01-02-2018 15:49:58

1,1K Tweet

2,2K Followers

1,1K Following

World Health Organization (WHO) Western Pacific (@whowpro) 's Twitter Profile Photo

Today is #WorldKidneyDay. Take care of your kidneys: 👍Maintain a healthy body weight 🥗Eat healthy 🏃‍♀️Be active 💧Drink water 🚭Don't smoke ❤Control your blood pressure 💊Don't self-medicate

Today is #WorldKidneyDay. Take care of your kidneys:

👍Maintain a healthy body weight
🥗Eat healthy
🏃‍♀️Be active
💧Drink water
🚭Don't smoke
❤Control your blood pressure
💊Don't self-medicate
World Kidney Day (@worldkidneyday) 's Twitter Profile Photo

Today is World Kidney Day 🎉 Celebrating 20 years of raising awareness about kidney health 🌍 The 2025 campaign #AreYourKidneysOK highlights the importance of #EarlyDetection in preventing and managing kidney disease. 👉 worldkidneyday.org/2025-campaign/ Share your WKD activity

Today is World Kidney Day 🎉 
Celebrating 20 years of raising awareness about kidney health 🌍

The 2025 campaign #AreYourKidneysOK highlights the importance of #EarlyDetection in preventing and managing kidney disease.

👉 worldkidneyday.org/2025-campaign/

Share your WKD activity
NKF Nephrology Professionals (@nkf_nephpros) 's Twitter Profile Photo

Kirk Campbell “33% of adults in the United States are at risk for kidney disease. But we need to look beyond the numbers. These are real people being affected.” shares Kirk Campbell. #NKFClinicals

<a href="/kirkcampbell/">Kirk Campbell</a> “33% of adults in the United States are at risk for kidney disease. But we need to look beyond the numbers. These are real people being affected.” shares <a href="/kirkcampbell/">Kirk Campbell</a>. #NKFClinicals
AJKD (@ajkdonline) 's Twitter Profile Photo

🎉 Congrats to Julie Wright Nunes et al whose paper has been selected for the "AJKD Editors' Choice: NKF Mission Award": Patient Education for CKD and Decision Support in Primary Care: Findings From the EPIK Pilot Study bit.ly/3QFxsf1 (FREE) #NKFClinicals University of Michigan - Division of Nephrology

🎉 Congrats to Julie Wright Nunes et al whose paper has been selected for the "AJKD Editors' Choice: NKF Mission Award":

Patient Education for CKD and Decision Support in Primary Care: Findings From the EPIK Pilot Study

bit.ly/3QFxsf1 (FREE)

#NKFClinicals <a href="/UMichKidney/">University of Michigan - Division of Nephrology</a>
ASN Publications (@asnpublications) 's Twitter Profile Photo

Exposure to heat indexes above 32.2°C was associated with greater weekly ED utilization and ED utilization with heat-related or kidney-related primary diagnosis codes. bit.ly/CJASN0699 #ASNCJASN

Exposure to heat indexes above 32.2°C was associated with greater weekly ED utilization and ED utilization with heat-related or kidney-related primary diagnosis codes. bit.ly/CJASN0699
#ASNCJASN
Rafael López Márquez (@rafaellpezmrqu2) 's Twitter Profile Photo

Kidney Dysfunction in Heart Failure: Core Curriculum 2025 1- beneficio en descongestión y desenlaces clínicos: mortalidad. Rehospitalización por falla cardiaca con diferentes estrategias de bloqueo secuencial de la nefrona 10.1053/j.ajkd.2024.12.006

Kidney Dysfunction in Heart Failure: Core Curriculum 2025

1- beneficio en descongestión y desenlaces clínicos: mortalidad. Rehospitalización por falla cardiaca con diferentes estrategias de bloqueo secuencial de la nefrona

10.1053/j.ajkd.2024.12.006
Rajiv Agarwal MD, MS (@agarwalrajivmd) 's Twitter Profile Photo

What % reduction in uACR are you expecting with the combination of empagliflozin & finerenone in type 2 diabetes & CKD at Day 180, as the #CONFIDENCE trial results are presented 5 June at #ERA25?

NEJM (@nejm) 's Twitter Profile Photo

Presented at #ERA25: In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results:

Presented at #ERA25: 

In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results:
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) nej.md/4jEVbbk #ERA25 | ERA - European Renal Association

Original Article: Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes (CONFIDENCE trial) nej.md/4jEVbbk  

#ERA25 | <a href="/ERAkidney/">ERA - European Renal Association</a>
ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

⏩ 4th presentation in Nephrology Innovations: Trials and Results #era25 📌A Nationwide Trial of Electronic Nudges to General Practices of Patients with Chronic Kidney Disease for Increasing Guideline-Directed Medical Therapy   🎙️ presented by Kristoffer Skaarup Kristoffer Grundtvig Skaarup

⏩ 4th presentation in Nephrology Innovations: Trials and Results #era25

📌A Nationwide Trial of Electronic Nudges to General Practices of Patients with Chronic Kidney Disease for Increasing Guideline-Directed Medical Therapy
 
🎙️ presented by Kristoffer Skaarup <a href="/KristofferSkaar/">Kristoffer Grundtvig Skaarup</a>
Niraj Kothari, MD (@nirajrkothari) 's Twitter Profile Photo

Honored to celebrate the first-ever #CMS Five Star Rating for #patientsafety and #quality care for ESKD patients at the Mount Sinai Kidney Center - 117th Street with Mount Sinai Hospital President and Chief Clinical Officer David L. Reich, MD.

Honored to celebrate the first-ever #CMS Five Star Rating for #patientsafety and #quality care for ESKD patients at the Mount Sinai Kidney Center - 117th Street with Mount Sinai Hospital President and Chief Clinical Officer <a href="/DrDavidReich/">David L. Reich, MD</a>.
Joseph Vassalotti, MD (@joe_vassalotti) 's Twitter Profile Photo

Stay cool & maintain adequate hydration during heat exposure, especially for people with CKD stages G3–G5, who were found to have higher rates of weekly ED visits for heat and kidney disease diagnoses in this nationwide analysis 916 thousand individuals. rb.gy/zdtbp3

Stay cool &amp; maintain adequate hydration during heat exposure, especially for people with CKD stages G3–G5, who were found to have higher rates of weekly ED visits for heat and kidney disease diagnoses in this nationwide analysis 916 thousand individuals. rb.gy/zdtbp3
JAMA (@jama_current) 's Twitter Profile Photo

Type 2 diabetes affects up to 14% of the global population. This Review discusses the diagnosis, treatment, and prognosis of adults with type 2 diabetes. ja.ma/3TQ3Z3m American Diabetes Association - DiabetesPro

Type 2 diabetes affects up to 14% of the global population. 

This Review discusses the diagnosis, treatment, and prognosis of adults with type 2 diabetes. 

ja.ma/3TQ3Z3m
<a href="/ADA_DiabetesPro/">American Diabetes Association - DiabetesPro</a>